Mounjaro availability in the UK: what's changed and how to access it now

You've searched for Mounjaro near you and the results are confusing

You may have called a local pharmacy and been told a particular pen is out of stock. You may have seen posts online claiming Mounjaro has been discontinued or is impossible to find. The reality is more nuanced. Mounjaro availability in the UK does shift by dose and by month. Eli Lilly has been scaling manufacturing to meet demand that grew faster than anyone anticipated after NICE recommended tirzepatide for weight management in December 2024. The result has been periodic tightness at mid-range doses rather than an end-to-end absence from the market. High-street pharmacies sometimes run dry on a specific strength while another is readily available. Online pharmacies that source through the licensed chain — and can show you their GPhC registration to prove it — typically have more flexibility across the dose range.

If your GP or a previous provider has mentioned supply difficulties, that is often a local or dose-specific picture. Checking with a regulated national provider is a reasonable next step. You can read more about current UK availability for a deeper breakdown of where things stand, including what the NHS rollout means for private stock.

One practical note: if you order before noon on a weekday, a prescription issued the same day can be dispatched the same afternoon and arrive with you the next working day, tracked by DPD. That rhythm matters if you are mid-treatment and watching a gap approach.

Why certain doses are harder to find than others

Mounjaro is titrated upward over several weeks or months, starting at 2.5mg. Most patients eventually reach a maintenance dose somewhere between 5mg and 15mg. Because the UK patient population on tirzepatide has grown rapidly, demand is weighted heavily toward the mid-range and higher doses, while the 2.5mg starter pen is generally more readily available. This is not a flaw in the system; it reflects a large number of people moving through treatment at the same time.

From a practical standpoint, tirzepatide's storage requirements also affect local pharmacy stock decisions. Each pen needs refrigeration, which limits how much a small dispensary can hold at once. Centralised online pharmacies with dedicated cold-chain logistics can often maintain broader stock across all six strengths. The full clinical profile of tirzepatide, including how the dose schedule works, sets useful context if you are newer to treatment.

What availability does not mean: a gap in stock at one provider is not a reason to seek the medicine through unverified sellers. The MHRA has warned publicly about counterfeit tirzepatide pens, including the raid of an illicit UK manufacturing site in Northampton in October 2025. Around 20 million doses of illegally traded weight-loss medicines were seized in 2025 alone. A short wait through a legitimate, GPhC-registered route is always safer than a fast delivery from an unknown one. You can verify any online pharmacy at the GPhC pharmacy register.

NHS availability versus private access: two very different timescales

NHS tirzepatide availability is phased deliberately. NICE's appraisal of Mounjaro (NICE TA1026) set out a staged rollout: from around June 2026, adults with a BMI of 35 to 39.9 alongside four or more weight-related conditions became eligible for Cohort 2 access. Even once eligible, patients need referral, a multidisciplinary pathway, and their local integrated care board to be actively commissioning. Many are waiting months. NHS weight-loss treatment pathways reflect this complexity accurately.

Private availability through a regulated pharmacy is a different route entirely. There is no waiting list and no referral needed; a prescriber assesses your suitability directly. You do still need a prescription, tirzepatide is a prescription-only medicine under UK law, and no legitimate provider can supply it any other way. What private access removes is the queue, not the clinical safeguard. Understanding what Mounjaro costs privately is useful context before starting, since pricing shifted significantly after Eli Lilly raised its UK list price in September 2025.

Is a tablet form of tirzepatide available in the UK?

Oral tirzepatide is not currently licensed in the UK for weight management. An injection is the only licensed form. If you have read about tablets, that is likely a reference to research-stage work or to Wegovy tablets (oral semaglutide, approved by the MHRA in June 2026), which is a different medicine entirely. For a clear answer on this specific question, our dedicated page on oral tirzepatide walks through what is and is not approved. Separately, if you are curious about expected future changes, this page covers the NHS rollout timeline and what criteria are expected to open up over the next year or two.

If you are ready to find out whether Mounjaro is right for you, our prescribers are available seven days a week. Speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not software, with same-day dispatch if you are approved and order before noon.